205 related articles for article (PubMed ID: 29735719)
1. Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.
Wei C; Stock L; Schneider-Gold C; Sommer C; Timchenko NA; Timchenko L
Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29735719
[TBL] [Abstract][Full Text] [Related]
2. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
4. Translational control of polyamine metabolism by CNBP is required for
Coni S; Falconio FA; Marzullo M; Munafò M; Zuliani B; Mosti F; Fatica A; Ianniello Z; Bordone R; Macone A; Agostinelli E; Perna A; Matkovic T; Sigrist S; Silvestri G; Canettieri G; Ciapponi L
Elife; 2021 Sep; 10():. PubMed ID: 34517941
[TBL] [Abstract][Full Text] [Related]
5. (CCUG)
Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
Meola G; Cardani R
Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
[TBL] [Abstract][Full Text] [Related]
7. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
[TBL] [Abstract][Full Text] [Related]
8. Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
Huichalaf C; Schoser B; Schneider-Gold C; Jin B; Sarkar P; Timchenko L
J Neurosci; 2009 Jul; 29(28):9042-9. PubMed ID: 19605641
[TBL] [Abstract][Full Text] [Related]
9. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?
Malatesta M
Eur J Histochem; 2012 Aug; 56(3):e36. PubMed ID: 23027352
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of protein homeostasis in myotonic dystrophies.
Meola G; Jones K; Wei C; Timchenko LT
Histol Histopathol; 2013 Sep; 28(9):1089-98. PubMed ID: 23536431
[TBL] [Abstract][Full Text] [Related]
12. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
[TBL] [Abstract][Full Text] [Related]
13. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
14. Modeling Myotonic Dystrophy Type 2 Using
Marzullo M; Coni S; De Simone A; Canettieri G; Ciapponi L
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762484
[TBL] [Abstract][Full Text] [Related]
15. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
16. Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2.
Kleefeld F; Horvath R; Pinal-Fernandez I; Mammen AL; Casal-Dominguez M; Hathazi D; Melchert S; Hahn K; Sickmann A; Muselmann-Genschow C; Hentschel A; Preuße C; Roos A; Schoser B; Stenzel W
Acta Neuropathol; 2024 Jan; 147(1):19. PubMed ID: 38240888
[TBL] [Abstract][Full Text] [Related]
17. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
Schneider-Gold C; Timchenko LT
Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
[TBL] [Abstract][Full Text] [Related]
18. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice.
Foltz SJ; Modi JN; Melick GA; Abousaud MI; Luan J; Fortunato MJ; Beedle AM
PLoS One; 2016; 11(1):e0147049. PubMed ID: 26751696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
